Tapewire

NYSE · USD

CVS

CVS HEALTH Corp

Export transactions ↓
Tapewire entity
2884
SEC CIK
0000064803
Parsed reports
1,748

Last 12 months

Inside the activity.

0 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202608
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 01, 2008 Filed Apr 3, 2008 20:31 UTC GrantCommon Stock (Restricted) 12,145 $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000047 · doc.xml · nonDerivative · entry 2

Roberts Jonathan C · CIK 0001410515 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,800

F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on 04/01/2013.

Read SEC document
April 01, 2008 Filed Apr 3, 2008 20:31 UTC
RYAN THOMAS MDirector · CEO & President
GrantStock Option · Derivative 634,233 $0.00 Strike: $41.17 $0.00
Disclosure

SEC source: 0000064803-08-000048 · doc.xml · derivative · entry 17

RYAN THOMAS M · CIK 0001194416 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 634,233

Underlying: Common Stock · 634,233 shares

Expires 2015-04-01

F6 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/1/2009.

Read SEC document
April 01, 2008 Filed Apr 3, 2008 20:31 UTC
RYAN THOMAS MDirector · CEO & President
GrantCommon Stock (Restricted) 133,593 $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000048 · doc.xml · nonDerivative · entry 2

RYAN THOMAS M · CIK 0001194416 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 988,704

F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 12/31/10 and 50% on 12/31/2011.

Read SEC document
April 01, 2008 Filed Apr 3, 2008 20:31 UTC
SGARRO DOUGLAS AExecutive Vice President
GrantStock Option · Derivative 172,973 $0.00 Strike: $41.17 $0.00
Disclosure

SEC source: 0000064803-08-000049 · doc.xml · derivative · entry 15

SGARRO DOUGLAS A · CIK 0001194417 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,973

Underlying: Common Stock · 172,973 shares

Expires 2015-04-01

F6 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/1/2009.

Read SEC document
April 01, 2008 Filed Apr 3, 2008 20:31 UTC
SGARRO DOUGLAS AExecutive Vice President
GrantCommon Stock (Restricted) 12,145 $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000049 · doc.xml · nonDerivative · entry 2

SGARRO DOUGLAS A · CIK 0001194417 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,536

F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse in two equal installments 50 % on 04/01/2011 and 50% on 04/22/2013.

Read SEC document
March 05, 2008 Filed Mar 6, 2008 21:27 UTC GrantShare Credits · Derivative 74.4786 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000033 · doc.xml · derivative · entry 2

DORMAN DAVID W · CIK 0001082870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,349.1492

Underlying: Common Stock · 73.7021 shares

Expires not disclosed

F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

Read SEC document
March 05, 2008 Filed Mar 6, 2008 21:23 UTC GrantCommon Stock 73 $40.28 $2,940.44
Disclosure

SEC source: 0000064803-08-000032 · doc.xml · nonDerivative · entry 2

BROWN C DAVID II · CIK 0001197672 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,277

F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan.

Read SEC document
March 05, 2008 Filed Mar 6, 2008 21:28 UTC GrantShare Credits · Derivative 49.6524 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000034 · doc.xml · derivative · entry 2

HEARD MARIAN L · CIK 0001198220 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,881.3682

Underlying: Common Stock · 48.8759 shares

Expires not disclosed

F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

Read SEC document
March 05, 2008 Filed Mar 6, 2008 21:30 UTC GrantShare Credits · Derivative 24.8262 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000035 · doc.xml · derivative · entry 2

JOYCE WILLIAM H · CIK 0001009124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,921.5832

Underlying: Common Stock · 24.4379 shares

Expires not disclosed

F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan.

F1 · derivative.exercise_date: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan.

F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

Read SEC document
March 05, 2008 Filed Mar 6, 2008 21:31 UTC GrantCommon Stock 73 $40.28 $2,940.44
Disclosure

SEC source: 0000064803-08-000036 · doc.xml · nonDerivative · entry 1

MILLON JEAN PIERRE · CIK 0001190016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229

F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan.

Read SEC document
March 05, 2008 Filed Mar 6, 2008 21:33 UTC GrantCommon Stock 73 $40.28 $2,940.44
Disclosure

SEC source: 0000064803-08-000038 · doc.xml · nonDerivative · entry 1

ROSENBERG SHELI Z · CIK 0001198222 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,609.6225

F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan.

F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year.

Read SEC document
March 05, 2008 Filed Mar 7, 2008 20:37 UTC
Denton David MController
GrantStock Option · Derivative 12,420 $0.00 Strike: $40.28 $0.00
Disclosure

SEC source: 0001428718-08-000002 · doc.xml · derivative · entry 9

Denton David M · CIK 0001428718 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,420

Underlying: Common Stock · 12,420 shares

Expires 2018-03-05

F4 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 3/5/2011.

Read SEC document
March 05, 2008 Filed Mar 7, 2008 20:37 UTC
Denton David MController
GrantCommon Stock (PEP) 1,242 $0.00 $0.00
Disclosure

SEC source: 0001428718-08-000002 · doc.xml · nonDerivative · entry 2

Denton David M · CIK 0001428718 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,242

Read SEC document
March 05, 2008 Filed Mar 7, 2008 20:37 UTC
Denton David MController
PurchaseCommon Stock 1,242 $40.23 $49,965.66
Disclosure

SEC source: 0001428718-08-000002 · doc.xml · nonDerivative · entry 1

Denton David M · CIK 0001428718 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,368.8343

Read SEC document
March 04, 2008 Filed Mar 6, 2008 21:27 UTC GrantShare Credits · Derivative 24.4379 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000033 · doc.xml · derivative · entry 1

DORMAN DAVID W · CIK 0001082870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,274.6706

Underlying: Common Stock · 24.4379 shares

Expires not disclosed

F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

Read SEC document
March 04, 2008 Filed Mar 6, 2008 21:23 UTC GrantCommon Stock 24 $40.92 $982.08
Disclosure

SEC source: 0000064803-08-000032 · doc.xml · nonDerivative · entry 1

BROWN C DAVID II · CIK 0001197672 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,204

F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan.

Read SEC document
March 04, 2008 Filed Mar 6, 2008 21:28 UTC GrantShare Credits · Derivative 48.8758 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000034 · doc.xml · derivative · entry 1

HEARD MARIAN L · CIK 0001198220 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,831.7158

Underlying: Common Stock · 48.8758 shares

Expires not disclosed

F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

Read SEC document
March 04, 2008 Filed Mar 6, 2008 21:30 UTC GrantShare Credits · Derivative 24.4379 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000035 · doc.xml · derivative · entry 1

JOYCE WILLIAM H · CIK 0001009124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,896.757

Underlying: Common Stock · 24.4379 shares

Expires not disclosed

F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan.

F1 · derivative.exercise_date: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan.

F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

Read SEC document
February 25, 2008 Filed Feb 26, 2008 21:48 UTC GrantShare Credits · Derivative 24.8385 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000029 · doc.xml · derivative · entry 1

HEARD MARIAN L · CIK 0001198220 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,782.84

Underlying: Common Stock · 24.8385 shares

Expires not disclosed

F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

Read SEC document
February 25, 2008 Filed Feb 26, 2008 21:48 UTC GrantShare Credits · Derivative 24.8385 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000030 · doc.xml · derivative · entry 1

JOYCE WILLIAM H · CIK 0001009124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,872.3191

Underlying: Common Stock · 24.8385 shares

Expires not disclosed

F1 · derivative.exercise_date: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan.

F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

Read SEC document
February 19, 2008 Filed Feb 21, 2008 21:34 UTC
RYAN THOMAS MDirector · CEO & President
Exercise / conversionStock Option · Derivative 1,200,000 $0.00 Strike: $18.66 $0.00
Disclosure

SEC source: 0000064803-08-000028 · doc.xml · derivative · entry 18

RYAN THOMAS M · CIK 0001194416 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,200,000 shares

Expires 2008-03-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 3/12/2001.

Read SEC document
February 19, 2008 Filed Feb 21, 2008 21:34 UTC
RYAN THOMAS MDirector · CEO & President
SaleCommon Stock 1,200,000 $40.01 $48,011,280.00
Disclosure

SEC source: 0000064803-08-000028 · doc.xml · nonDerivative · entry 2

RYAN THOMAS M · CIK 0001194416 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 631,549

F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $39.7050 and 40.3450 per share.

F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan.

Read SEC document
February 19, 2008 Filed Feb 21, 2008 21:34 UTC
RYAN THOMAS MDirector · CEO & President
Exercise / conversionCommon Stock 1,200,000 $18.66 $22,387,560.00
Disclosure

SEC source: 0000064803-08-000028 · doc.xml · nonDerivative · entry 1

RYAN THOMAS M · CIK 0001194416 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,831,549

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan.

Read SEC document
February 15, 2008 Filed Mar 6, 2008 21:32 UTC Tax withholdingCommon Stock 1,254 $39.72 $49,808.88
Disclosure

SEC source: 0000064803-08-000037 · doc.xml · nonDerivative · entry 1

Roberts Jonathan C · CIK 0001410515 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,242

Read SEC document
February 12, 2008 Filed Feb 13, 2008 21:08 UTC GrantCommon Stock 48 $40.36 $1,937.28
Disclosure

SEC source: 0000064803-08-000016 · doc.xml · nonDerivative · entry 1

ROSENBERG SHELI Z · CIK 0001198222 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,512.6225

F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan.

F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year.

Read SEC document
February 12, 2008 Filed Feb 13, 2008 21:20 UTC GrantShare Credits · Derivative 49.554 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000019 · doc.xml · derivative · entry 1

DORMAN DAVID W · CIK 0001082870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,250.2327

Underlying: Common Stock · 49.554 shares

Expires not disclosed

F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

Read SEC document
February 12, 2008 Filed Feb 13, 2008 21:17 UTC GrantShare Credits · Derivative 24.777 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000018 · doc.xml · derivative · entry 1

HEARD MARIAN L · CIK 0001198220 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,758.0015

Underlying: Common Stock · 24.777 shares

Expires not disclosed

F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan.

F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election.

F1 · derivative.underlying_shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan.

Read SEC document
February 12, 2008 Filed Feb 13, 2008 21:13 UTC GrantCommon Stock 24 $40.36 $968.64
Disclosure

SEC source: 0000064803-08-000017 · doc.xml · nonDerivative · entry 1

MILLON JEAN PIERRE · CIK 0001190016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156

F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan.

Read SEC document
February 12, 2008 Filed Feb 13, 2008 21:24 UTC GrantCommon Stock 48 $40.36 $1,937.28
Disclosure

SEC source: 0000064803-08-000020 · doc.xml · nonDerivative · entry 1

BROWN C DAVID II · CIK 0001197672 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,180

F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan.

Read SEC document
February 12, 2008 Filed Feb 14, 2008 21:51 UTC
BODINE CHRIS WExecutive Vice President
GrantStock Unit 14,494 $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000021 · doc.xml · nonDerivative · entry 3

BODINE CHRIS W · CIK 0001194405 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,648.9257

F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer.

Read SEC document
February 12, 2008 Filed Feb 14, 2008 21:52 UTC
FERDINANDI V MICHAELSenior Vice President
GrantStock Unit 11,595 $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000022 · doc.xml · nonDerivative · entry 4

FERDINANDI V MICHAEL · CIK 0001194412 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,795.4366

F3 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer.

Read SEC document
February 12, 2008 Filed Feb 14, 2008 21:52 UTC
MERLO LARRY JExecutive Vice President
GrantStock Unit 14,494 $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000023 · doc.xml · nonDerivative · entry 3

MERLO LARRY J · CIK 0001194413 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,648.9257

F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer.

Read SEC document
February 12, 2008 Filed Feb 14, 2008 21:53 UTC
RICKARD DAVID BChief Financial Officer
GrantStock Unit 14,494 $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000024 · doc.xml · nonDerivative · entry 3

RICKARD DAVID B · CIK 0001194414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,648.9257

F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer.

Read SEC document
February 12, 2008 Filed Feb 14, 2008 21:53 UTC
RYAN THOMAS MDirector · CEO & President
GrantStock Unit 69,573 $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000025 · doc.xml · nonDerivative · entry 3

RYAN THOMAS M · CIK 0001194416 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 463,012.1101

F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer.

Read SEC document
February 12, 2008 Filed Feb 14, 2008 21:53 UTC
SGARRO DOUGLAS AExecutive Vice President
GrantStock Unit 14,494 $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000026 · doc.xml · nonDerivative · entry 3

SGARRO DOUGLAS A · CIK 0001194417 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,310.4366

F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer.

Read SEC document
February 12, 2008 Filed Feb 14, 2008 21:53 UTC
Price Paula AController
GrantCommon Stock (Restricted) 5,018 $0.00 $0.00
Disclosure

SEC source: 0000064803-08-000027 · doc.xml · nonDerivative · entry 2

Price Paula A · CIK 0001369240 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,498

F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse in three equal annual installments commencing 2/12/2009.

Read SEC document
February 11, 2008 Filed Feb 11, 2008 21:15 UTC
MCLURE HOWARD APresident, Caremark Pharm Serv
Exercise / conversionStock Option · Derivative 225,000 $0.00 Strike: $20.23 $0.00
Disclosure

SEC source: 0000064803-08-000014 · doc.xml · derivative · entry 20

MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,258

Underlying: Common Stock · 225,000 shares

Expires 2015-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
February 11, 2008 Filed Feb 11, 2008 21:15 UTC
MCLURE HOWARD APresident, Caremark Pharm Serv
SaleCommon Stock 225,000 $40.06 $9,013,972.50
Disclosure

SEC source: 0000064803-08-000014 · doc.xml · nonDerivative · entry 9

MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,379

F1 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $40.00 and $40.16 per share.

Read SEC document
February 11, 2008 Filed Feb 11, 2008 21:15 UTC
MCLURE HOWARD APresident, Caremark Pharm Serv
SaleCommon Stock 11,379 $39.63 $450,974.80
Disclosure

SEC source: 0000064803-08-000014 · doc.xml · nonDerivative · entry 8

MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 236,379

Read SEC document
February 11, 2008 Filed Feb 11, 2008 21:15 UTC
MCLURE HOWARD APresident, Caremark Pharm Serv
SaleCommon Stock 13,621 $39.63 $539,830.20
Disclosure

SEC source: 0000064803-08-000014 · doc.xml · nonDerivative · entry 7

MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 247,758

Read SEC document
February 11, 2008 Filed Feb 11, 2008 21:15 UTC
MCLURE HOWARD APresident, Caremark Pharm Serv
Exercise / conversionCommon Stock 225,000 $20.23 $4,551,750.00
Disclosure

SEC source: 0000064803-08-000014 · doc.xml · nonDerivative · entry 6

MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261,379

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 11, 2008 Filed Feb 12, 2008 21:31 UTC
PICCOLO C ADirector
Exercise / conversionStock Option · Derivative 46,856 $0.00 Strike: $13.41 $0.00
Disclosure

SEC source: 0000064803-08-000015 · doc.xml · derivative · entry 9

PICCOLO C A · CIK 0001192152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 46,856 shares

Expires 2014-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
February 11, 2008 Filed Feb 12, 2008 21:31 UTC
PICCOLO C ADirector
Exercise / conversionStock Option · Derivative 46,849 $0.00 Strike: $9.17 $0.00
Disclosure

SEC source: 0000064803-08-000015 · doc.xml · derivative · entry 8

PICCOLO C A · CIK 0001192152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 46,849 shares

Expires 2013-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
February 11, 2008 Filed Feb 12, 2008 21:31 UTC
PICCOLO C ADirector
Exercise / conversionStock Option · Derivative 46,844 $0.00 Strike: $8.42 $0.00
Disclosure

SEC source: 0000064803-08-000015 · doc.xml · derivative · entry 7

PICCOLO C A · CIK 0001192152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 46,844 shares

Expires 2012-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
February 11, 2008 Filed Feb 12, 2008 21:31 UTC
PICCOLO C ADirector
SaleCommon Stock 140,549 $39.83 $5,598,586.70
Disclosure

SEC source: 0000064803-08-000015 · doc.xml · nonDerivative · entry 4

PICCOLO C A · CIK 0001192152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,025

F1 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $39.40 and $40.04 per share.

Read SEC document
February 11, 2008 Filed Feb 12, 2008 21:31 UTC
PICCOLO C ADirector
Exercise / conversionCommon Stock 46,856 $13.41 $628,338.96
Disclosure

SEC source: 0000064803-08-000015 · doc.xml · nonDerivative · entry 3

PICCOLO C A · CIK 0001192152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,574

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 11, 2008 Filed Feb 12, 2008 21:31 UTC
PICCOLO C ADirector
Exercise / conversionCommon Stock 46,849 $9.17 $429,605.33
Disclosure

SEC source: 0000064803-08-000015 · doc.xml · nonDerivative · entry 2

PICCOLO C A · CIK 0001192152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262,718

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 11, 2008 Filed Feb 12, 2008 21:31 UTC
PICCOLO C ADirector
Exercise / conversionCommon Stock 46,844 $8.42 $394,426.48
Disclosure

SEC source: 0000064803-08-000015 · doc.xml · nonDerivative · entry 1

PICCOLO C A · CIK 0001192152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,869

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 08, 2008 Filed Feb 11, 2008 21:15 UTC
MCLURE HOWARD APresident, Caremark Pharm Serv
Exercise / conversionStock Option · Derivative 13,621 $0.00 Strike: $20.23 $0.00
Disclosure

SEC source: 0000064803-08-000014 · doc.xml · derivative · entry 19

MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 361,258

Underlying: Common Stock · 13,621 shares

Expires 2015-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
February 08, 2008 Filed Feb 11, 2008 21:15 UTC
MCLURE HOWARD APresident, Caremark Pharm Serv
Exercise / conversionStock Option · Derivative 11,379 $0.00 Strike: $17.08 $0.00
Disclosure

SEC source: 0000064803-08-000014 · doc.xml · derivative · entry 18

MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,379 shares

Expires 2014-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.